Session 1: Acute Coronary Syndrome
Acute Coronary Syndrome is the decrease in the blood flow in the coronary arteries such that the part of the heart muscle cannot work properly. It can be easily get diagnosed by Electrocardiogram either by ST elevation or by Non-ST elevation. Acute Coronary Syndrome is usually associated with coronary thrombosis; it can also be associated with cocaine use. The importance of coronary heart disease risk factors may differ between individuals and community and by sex and age. In women, relative risks ranged from 2.74 to 1.19 with the highest risks for diabetes, smoking, hypertension, and physical inactivity.
Session 2: Heart Arrhythmia
Heart Arrhythmia is nothing but an irregular heartbeat. If a heartbeat is too fast then it is called Tachycardia .i.e., above 100 beats per minute in adults. Some predispose a person to complications such as stroke. Arrhythmia symptoms may include slow heartbeat, chest pain, sweating, fainting, and a fluttering in your chest. Arrhythmias due to medications have been reported since the 1920s with the use of quinine In the 1960s and 1970s problems with antihistamines and antipsychotics were discovered.
Session 3: Dilated cardiomyopathy
Dilated cardiomyopathy is which the heart becomes enlarged and cannot able to pump blood effectively. Symptoms vary from none to leg swelling, feeling tired, it may also leads to chest pain. Causes include genetics, certain alcohol, complications of pregnancy .The diagnosis such as medical therapy and electrical treatment, Electrocardiogram. It can happen in any stage and may include swelling of your legs, fatigue. In this study, we aimed to determine the outcome of children with idiopathic dilated cardiomyopathy and features that might be useful as prognostic indicators.
Session 4: Congenital Heart Disease.
Congenital Heart Disease is the problem of the structure of heart that is present at the birth. Symptoms may vary none to life threatening. Adults with congenital heart disease (CHD) are rapidly increasing in numbers in developed countries where facilities for interventions for CHD are available to infants and children. Over 90 % of children survive to adulthood in these countries. However, less than 50 % of children born in developing countries undergo any form of intervention due to no availability of paediatric cardiac centres. Prevalence of CHD in adults is estimated at 3000 per million population in developed countries. .
Session 5: Atrial Ventricular Block
It is the condition that the conduction between the atrium and ventricles of heart is impaired. Under normal conditions, (SA node) in the atria set the pace for the heart, and these impulses travel to the ventricles. In an AV block, this does not reach the ventricles or is impaired along the way. It includes degrees of heart block like first, second and third degrees of heart block. This session will give the complete information about the AV block. The incidence of early atrioventricular conduction block requiring a pacemaker was 0.9% and that of delayed atrioventricular conduction block was 0.3% to 0.7%. Transient atrioventricular conduction block may be a marker for increased risk of delayed block. These data may be useful for evaluation of new techniques.
Session 6: Mitral Stenosis
It is the narrowing of the mitral valve opening that blocks blood flow from the left atrium to the left ventricle. Only when the condition is severe or else it doesn’t show any symptoms. The causes of this include calcium deposits, rheumatic fever, pulmonary, congestion, and dyspnea. The complications are atrial fibrillation, endocarditis, dysphagia, and embolism. From July 1996 to June 2007, 78 patients underwent mitral valve repair for rheumatic valve disease. Over the same time interval, 54 patients underwent mitral valve replacement. Mean age was 56.4 ± 16 years.
.Session 7:. Atherosclerosis
Atherosclerosis is a common form of heart disease of the arteries characterized by the deposition of plaques of fatty material on the inner walls eventually restricts blood flow and plaque is made up of fat, cholesterol, calcium, and other substances found in the blood later Plaque narrows your arteries which lacks the flow of oxygen-rich blood to your organs and other parts of your body and this constricted circulation leads to less oxygen for the heart muscle, resulting in chest pain , usually following exercise or excitement.
Cardiac-oncology is the intersection of heart condition in which patients that have been treated for cancer. There are several reasons for both diseases occurring in the same patient. Coronary artery disease and Cancer share risk factors such as age, more use of tobacco and obesity. These treatments have directly impact on the heart, which require, in some cases, surgical correction. Malignancy (having cancer cells) can also occur during long-term follow-up after Coronary artery bypass graft (CABG). Few studies directly addressing the benefits of screening for long-term cardiac or pulmonary toxicity in asymptomatic cancer survivors who received chemotherapy, radiotherapy were identified. The reviewed literature includes primarily retrospective and cross-sectional studies describing the incidence of cardiac and pulmonary late effects.
Session 9: Heart regeneration
Heart regeneration is a big effort to regenerate the heart tissue. Working together providers are finding solutions that restore, and recycle patients own reparative capacity. Through the generous support, strong efforts are developed discoveries that will have a global impact on ischemic heart disease. Stem cell therapy for cardiac disease is an exciting but highly controversial research area. Strategies such as cell transplantation and reprogramming have demonstrated both intriguing and sobering results. In this session we will discuss more about the heart regeneration strategies.
Session 10: Clinical cardiology
Clinical Cardiology includes studies related to cardiac diseases congenital heart diseases, coronary artery disease, heart failure, cardiovascular heart disease, and their epidemiology and pathophysiology of the heart. The therapeutic procedure involves diagnosis and management of cardiac diseases like electrophysiology, cardiovascular devices, cardiac regeneration, cardiac medicine, cardiac surgery, and identification of risk factors for cardiovascular diseases. A Guideline is given for the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anaesthesia
Session 11:Critical Cardiac care
Critical cardiac care (CIC) which is also known as Coronary care unit(CCU) is a hospital ward specialized in the care of patients who are with heart attacks, unstable angina, cardiac dysrhythmia and various other cardiac conditions that requires continuous monitoring and till the doctor comes. There are many units available in the hospitals to take care of the emergency situation. Cardiac biomarkers are integral to the diagnosis and the treatment of acutely ill cardiac patients.
Session 12: Cardiac imaging
The cardiac imaging also known as cardiovascular magnetic resonance imaging (CMR), is a imaging for the assessment of the activity and structure of the cardiovascular system with division of Cardiovascular Imaging clarifies the cross sectional imaging studies of the heart and vascular system using Computed Tomography (CT or "CAT" scans) and Magnetic Resonance Imaging (MRI). Both CT and MRI are non-invasive imaging modalities. A preliminary report on medical radiation exposures to the US population based on publicly available sources of data estimated that the collective dose received from medical uses of radiation has increased by >700% between 1980 and 2006.
“International heart conference” It is three day programme of presentation, panel discussions and interactive dialogue at conference on leading the way in the research field of cardiology. Cardiology is the branch of medicine dealing with the disorders of the heart. It’s going to be held in Singapore city, Singapore on August 20-22, 2018.
Cardiology is a branch of medicine which deals with disorders of heart as well as functioning of heart. This field includes medical diagnosis and medical treatment of congenital heart disease etc. At present many of the people are suffering from heart diseases. The analysis of the heart diseases in every zone of the world is different. Mostly it is seen in the old aged people and mortality rate also decreasing.
The European market for interventional cardiology is leading towards maturity, mostly in Western Europe. Although the economic slowdown had a negative impact on revenues in 2012, it is expected that expanding applications of interventional systems and the popularisation of hybrid solutions will drive market growth over the 2013-2017 period.
Market Trends in Europe Interventional Cardiology, finds that the market earned approximately $336.7 million in 2012 and estimates this to reach $352.6 million in 2016. Novel applications, the demand for hybrid solutions and the need for new systems in Eastern Europe will fuel market growth.
Geographically, North America has the highest market share in 2013 due to high awareness about the heart diseases. According to the Centres for Disease Control and Prevention (CDC), every year about 610,000 people in America die of heart diseases. Likewise, annually 735,000 Americans are victims of heart attacks. Thus, increasing of heart attacks in North America would increase the demand of cardiovascular drugs. However, Asia-Pacific region is expected to showcase the fastest growth rate in the future due to rise in aging population, increasing awareness and in other factors.
In Middle East:
Countries in Middle East and Africa bear a heavy burden from Ischemic heart disease. According to, Dubai Health Authority, Heart disease is the cause for every 3 in 10 deaths in the UAE. Huge funding in R&D and various initiatives by government is driving the growth for Ischemic heart Disease market in Middle East and Africa.
Middle-East and Africa Ischemic heart Disease market is growing steadily. The market is growing at the CAGR of 3.1% and expected to reach to US$ 2.84 billion by 2022.
Around 5 million Americans suffer from heart valve disease every year. Heart disease is considered as one of the leading cause of mortality. Thus substantial rise in burden of heart valve disease is the major growth driver for the heart valve device market. Geographically, this report split Asia-Pacific into several key Regions, with sales (MT), revenue (Million USD), and market share and growth rate of Ischemic Heart Disease Drugs for these regions, from 2012 to 2022.
Cardiology Associations and Societies: